RBC Bioscience

RBC Bioscience Rule of 40

The Rule of 40 of RBC Bioscience (6848.TWO) as of Oct 22, 2026 is 36.45 %. In the previous year, Rule of 40 was 7.61 % — a change of 378.87% (higher).

Rule of 40

36.45 %

YoY

378.87%

Last updated:

Rule of 40 of RBC Bioscience is 2024 36.45 % . Rule of 40 of RBC Bioscience was 2023 7.61 % . It decreases by 378.87% higher compared to the previous year.

The RBC Bioscience Rule of 40 history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Rule of 40
Date
Rule of 40
Jan 1, 2019
40.36 TWD
Jan 1, 2020
288.50 TWD
Jan 1, 2021
-36.98 TWD
Jan 1, 2022
-26.31 TWD
Jan 1, 2023
7.61 TWD
Jan 1, 2024
36.45 TWD
The RBC Bioscience Rule of 40 history
YEARRule of 40YoY
36.45 %+378.87%
7.61 %-128.92%
-26.31 %-28.83%
-36.98 %-112.82%
288.50 %+614.77%
40.36 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

RBC Bioscience Stock analysis

What does RBC Bioscience do? RBC Bioscience Corp manufactures reagents and devices for life science and molecular diagnosis. The company's products include instruments equipped with ultraviolet sterilization systems for nucleic acid purification and disposable reagent strips and tips that work with built-in control programs for different nucleic acid extraction types. The firm developed nucleic acid purification reagents with cellulose-embedded magnetic beads to improve DNA and RNA purity for blood, bacteria, viruses, and forensic examinations. These products are used for future diagnosis, prevention, tracking, and treatment of diseases. The company sells its instruments and reagents to customers in life science and molecular diagnosis sectors. The instruments feature ultraviolet sterilization systems, while the reagents include disposable strips and tips with varying control programs. The reagents with cellulose-embedded magnetic beads are designed for high-purity nucleic acid extraction from diverse samples including blood, bacteria, viruses, and forensic materials. RBC Bioscience Corp's revenue comes from the sale of instruments and reagents. The instruments are sold to laboratories and medical facilities requiring nucleic acid purification systems. The reagents, including the disposable strips and tips, are sold alongside the instruments or separately for ongoing use in molecular diagnosis processes. RBC Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about RBC Bioscience stock

Rule of 40 of RBC Bioscience is 36.45 % in 2024.

On Eulerpool you can find the complete historical development of Rule of 40 RBC Bioscience since 2006 – with annual values, charts, and detailed analysis.

The Rule of 40 states that a company's revenue growth rate plus profit margin should exceed 40%. It is widely used to evaluate SaaS and high-growth companies.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — RBC Bioscience

All Key Metrics — RBC Bioscience